Related Experiment Video

Updated: Aug 19, 2026

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

[Gene therapy]

Akinobu Gotoh1, Toshiro Shirakawa, Yoshitaka Wada

  • 1The International Center for Medical Research, Kobe University School of Medicine.

Hinyokika Kiyo. Acta Urologica Japonica
|March 19, 2005
PubMed

Insights

This study explores suicide gene therapy for bone-metastatic prostate cancer using an adenovirus vector. While early clinical trials show safety, further development is needed for this promising recurrent prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Context:

  • Recurrent prostate cancer, particularly bone metastases, presents significant therapeutic challenges.
  • Existing treatments for advanced prostate cancer have limitations.
  • Gene therapy offers a novel approach to target cancer cells specifically.

Purpose:

  • To develop and evaluate a suicide gene therapy for bone-metastatic prostate cancer.
  • To utilize an adenovirus vector with an organ-specific osteocalcin promoter for targeted delivery.
  • To present findings from basic research through clinical stages and ongoing studies.

Summary:

  • A suicide gene therapy using an adenovirus vector and an osteocalcin promoter was developed for bone-metastatic prostate cancer.
  • Clinical studies, including those initiated in August 2003, have demonstrated the safety of this approach.
  • The research highlights gene therapy's potential as a future treatment for recurrent prostate cancer, despite current developmental immaturity.

Impact:

  • Establishes the safety profile of adenovirus-mediated suicide gene therapy in prostate cancer patients.
  • Provides a foundation for further translational research and clinical development of gene therapy for recurrent prostate cancer.
  • Highlights the evolving landscape of cancer therapeutics, with gene therapy emerging as a key area of focus.

More Related Videos

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...